Geode Capital Management, LLC Cardiff Oncology, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 928,232 shares of CRDF stock, worth $3.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

928,232

Previous 910,675 1.93%

Holding current value

$3.74 Million

Previous $2.02 Million 22.61%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.05 - $2.77 $35,991 - $48,632	17,557 Added 1.93%	928,232 $2.48 Million
Q2 2024 Aug 09, 2024	BUY	$2.22 - $5.89 $1.06 Million - $2.8 Million	475,842 Added 109.43%	910,675 $2.02 Million
Q1 2024 May 13, 2024	BUY	$1.46 - $5.91 $15,661 - $63,396	10,727 Added 2.53%	434,833 $2.32 Million
Q4 2023 Feb 13, 2024	BUY	$0.96 - $1.55 $30,527 - $49,288	31,799 Added 8.11%	424,106 $627,000
Q3 2023 Nov 13, 2023	BUY	$1.38 - $2.18 $15,396 - $24,322	11,157 Added 2.93%	392,307 $545,000
Q2 2023 Aug 11, 2023	SELL	$1.37 - $1.95 $44,322 - $63,086	-32,352 Reduced 7.82%	381,150 $560,000
Q4 2022 Feb 13, 2023	SELL	$1.22 - $1.66 $1,061 - $1,444	-870 Reduced 0.21%	413,502 $578,000
Q3 2022 Nov 14, 2022	BUY	$1.54 - $3.21 $3,483 - $7,261	2,262 Added 0.55%	414,372 $638,000
Q2 2022 Aug 12, 2022	SELL	$1.17 - $2.61 $301,531 - $672,646	-257,719 Reduced 38.48%	412,110 $906,000
Q1 2022 May 13, 2022	BUY	$2.11 - $7.25 $52,211 - $179,401	24,745 Added 3.84%	669,829 $1.66 Million
Q4 2021 Feb 11, 2022	BUY	$5.18 - $7.24 $325,961 - $455,591	62,927 Added 10.81%	645,084 $3.88 Million
Q3 2021 Nov 12, 2021	BUY	$5.01 - $7.58 $336,551 - $509,194	67,176 Added 13.04%	582,157 $3.88 Million
Q2 2021 Aug 13, 2021	BUY	$6.65 - $10.04 $2.04 Million - $3.08 Million	306,526 Added 147.05%	514,981 $3.42 Million
Q1 2021 May 12, 2021	BUY	$9.1 - $19.57 $50,677 - $108,985	5,569 Added 2.74%	208,455 $1.93 Million
Q4 2020 Feb 12, 2021	BUY	$12.02 - $24.71 $1.16 Million - $2.38 Million	96,327 Added 90.4%	202,886 $3.65 Million
Q3 2020 Nov 13, 2020	BUY	$4.25 - $14.19 $281,702 - $940,555	66,283 Added 164.57%	106,559 $1.51 Million
Q2 2020 Aug 13, 2020	BUY	$0.78 - $5.1 $31,415 - $205,407	40,276 New	40,276 $201,000

Others Institutions Holding CRDF

# of Institutions

Shares Held

12.3M

Call Options Held

813K

Put Options Held

91.1K

View Full List

About Cardiff Oncology, Inc.

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $175M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

More about CRDF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cardiff Oncology, Inc. Transaction History